Related Experiment Video
Updated: Feb 1, 2026

Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans
Published on: February 22, 2015
Cryoprotectant toxicity in Caenorhabditis elegans
Patricia M Tedesco1, Garrett J Schumacher1, Thomas E Johnson2
1Institute for Behavioral Genetics, University of Colorado, Boulder, USA.
Abstract:
We have looked at the effects of the cryoprotectant M22 upon viability in the model organism C. elegans. M22 is a well-known vitrification solution which has been successfully used in the laboratory to preserve organs destined for transplantation. M22 reduces survival of C. elegans in a concentration-dependent manner. M22 at concentrations of 10% (v/v) or higher inhibits progeny production and development. A few mutants in the ILS (insulin-like signaling) pathway of C. elegans are more resistant to the toxic effect of M22 compared to wild-type worms. Afatinib, an anti-cancer drug, protects against M22 toxicity. Afatinib by itself does not increase longevity.
Insights
The cryoprotectant M22 harms Caenorhabditis elegans survival and development in a dose-dependent way. However, certain insulin-like signaling pathway mutants and the drug afatinib show resistance to M22 toxicity.
Area of Science:
- Cryobiology
- Toxicology
- Developmental Biology
Background:
- Cryoprotective agents are crucial for preserving biological samples and organs.
- M22 is a common vitrification solution used in organ transplantation.
- Understanding the toxicity of cryoprotectants in model organisms is essential for improving preservation techniques.
Purpose of the Study:
- To investigate the toxic effects of the cryoprotectant M22 on the survival and reproductive capacity of Caenorhabditis elegans.
- To identify genetic factors or pharmacological interventions that confer resistance to M22 toxicity.
Main Methods:
- Exposure of C. elegans wild-type and mutant strains to various concentrations of M22.
- Assessment of worm survival, progeny production, and developmental progression.
- Evaluation of the protective effect of afatinib against M22-induced toxicity.
Main Results:
- M22 exhibits concentration-dependent toxicity, reducing C. elegans survival and inhibiting development at concentrations of 10% (v/v) and above.
- Mutants in the insulin-like signaling (ILS) pathway demonstrate increased resistance to M22 toxicity compared to wild-type worms.
- Afatinib, an anti-cancer drug, effectively protects C. elegans against M22 toxicity without affecting lifespan.
Conclusions:
- M22 poses a significant toxicity risk to C. elegans, impacting survival and development.
- The insulin-like signaling pathway plays a role in M22 tolerance.
- Afatinib represents a potential therapeutic strategy to mitigate cryoprotectant toxicity in C. elegans.
More Related Videos
Related Concept Videos
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Frequency-dependent Selection
Predator-Prey Interactions
Responses to Salt Stress
Comparative Excretory Systems
The Stanford Prison Experiment

